Balyasny Asset Management
LUXA

Balyasny Asset Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Balyasny Asset Management’s Portfolio LUXA Stock Details LUXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,242,551
Closed -$12.4M – 3551
2022
Q3 		$12.4M Buy
1,242,551
+41
+0% +$408 0.04% 591
2022
Q2 		$12.3M Hold
1,242,510
– – 0.04% 584
2022
Q1 		$12.3M Hold
1,242,510
– – 0.04% 620
2021
Q4 		$12.2M Hold
1,242,510
– – 0.04% 576
2021
Q3 		$12.2M Hold
1,242,510
– – 0.05% 497
2021
Q2 		$12.3M Buy
1,242,510
+574,644
+86% +$5.78M 0.06% 441
2021
Q1 		$6.86M Buy
+667,866
New +$7.41M 0.03% 587

Balyasny Asset Management's LUXA Position: Q4 2022 in Review

Balyasny Asset Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 1,242,551 shares — an estimated $12.4M sold.

Balyasny Asset Management first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $12.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Balyasny Asset Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 1,242,551 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $12.4M.
  • Balyasny Asset Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Balyasny Asset Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $12.4M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.